UPDATE : Monday, September 7, 2020
상단여백
GC sells off North America business to Grifols by Lee Han-soo 2020-07-21 18:31
Helixmith to start trials of VM202 for treating rare disorder by Lee Han-soo 2020-07-21 17:10
Genexine, Y Biologics to co-develop Covid-19 treatment by Lee Han-soo 2020-07-21 15:52
GC LabCell’s tech wins patent for delivering gene therapy to brain by Shim Hyun-tai 2020-07-21 15:52
'Severe atopic dermatitis drug too expensive for adolescents' by Kim Eun-young 2020-07-21 14:20
라인
GC makes plasma Covid-19 therapy for clinical trials by Shim Hyun-tai 2020-07-20 17:30
Eutilex’s cancer therapy won Canadian patent by Shim Hyun-tai 2020-07-17 17:52
Hanmi’s fatty liver drug won FDA’s fast-track designation by Shim Hyun-tai 2020-07-16 15:57
‘Stage-3 unresectable lung cancer patient has every reason to use Imfinzi’ by Kim Yun-mi 2020-07-16 14:37
Menarini Korea deletes controversial YouTube ad by Kim Chan-hyuk 2020-07-16 14:16
라인
Samsung Biologics to develop 5 more cancer therapies of ImmuneOncia by Shim Hyun-tai 2020-07-15 18:33
Biogen, Esai to test another Alzheimer’s drug in phase-3 study by Kim Yun-mi 2020-07-15 12:42
Medytox, Daewoong keep brawling over US agency’s ruling by Lee Han-soo 2020-07-14 17:30
Hanmi Science, Bioapp to start full-scale development of Green bio-based COVID-19 vaccine by Lee Han-soo 2020-07-14 14:58
LSK Global PS chosen as CRO of IVI's Covid-19 vaccine trials by Lee Han-soo 2020-07-13 15:48
라인
‘Remdesivir cut death risk by 62% in severely ill Covid-19 patients’ by Kim Yun-mi 2020-07-13 14:44
Regulator OKs Samyang’s breast cancer treatment by Lee Han-soo 2020-07-13 14:38
Multinational drugmakers seek to form new trade union by Kim Yun-mi 2020-07-13 11:44
Ministry OKs Dongkook's P3 trial into benign prostatic hyperplasia treatment by Lee Han-soo 2020-07-10 16:54
Court rejects Medytox's request not to revoke license of Medytoxin by Lee Han-soo 2020-07-10 14:59
여백
여백
여백
Back to Top